Polymorphisms in Inflammatory Cytokines Genes in Subjects With Obstructive Sleep Apnea

NCT ID: NCT00395590

Last Updated: 2006-11-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-11-30

Study Completion Date

2007-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Obstructive sleep apnea is a common sleep disorder. It is known to be related with increased body mass, abdominal obesity, insulin resistance and hypertension. It is currently believed to be a feature of the metabolic syndrome. Other features of the metabolic syndrome-such as insulin resistace were found related to inflammation and inflammatory cytokines. Several polymorphisms in the genes that encode interleukin 6,inteleukin 10 and TNF-alpha have significant influence on the amounts of cytokine production. we thus hypothesize that polymorphisms related to increased pruduction are more common in subjects with OSA than in matched controls

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients attending a sleep apnea clinic for evluation will be recruited. Patients found positive for OSA will be compared to the patients with a negative study for OSA for the prevalence of polymorphisms in genes of inflammatory cytokines and cytokine levels

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Apnea

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

OSA inflammatory cytokines, metabolic syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

DEFINED_POPULATION

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients attending the sleep apnea clinic for evaluation

Exclusion Criteria

* patients known to have inflammatory conditions
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shaare Zedek Medical Center

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

mates mates, MD

Role: STUDY_DIRECTOR

Ben-Gurion University of the Negev

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

michal mates, MD

Role: CONTACT

Phone: 02-6555111

Email: [email protected]

Gheona Altarescu

Role: CONTACT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5594ctil

Identifier Type: -

Identifier Source: org_study_id